Healthcare demands new computing paradigms to meet the need for personalized medicine, next-generation clinics, enhanced quality of care, and breakthroughs in biomedical research to treat disease. With NVIDIA, healthcare institutions can harness the power of AI and high-performance computing (HPC) to define the future of medicine.
The new NVIDIA NIM™ Agent Blueprint contains three microservices—AlphaFold2, DiffDock, and MolMIM—that accelerate the virtual screening of small molecules using generative models.
NIM Agent Blueprints provide a jump-start for developers creating AI applications that package one or more NIM microservices.
NIM Agent Blueprints, sample-packaged AI workflows, include a generative AI-based virtual screening workflow for accelerated drug discovery.
With accelerated computing, researchers can virtually model millions of molecules and screen hundreds of potential drugs simultaneously, reducing costs and speeding time- to- solution.
Using HPC to accelerate genome analysis in population and cancer genomic studies can help identify rare diseases and bring tailored therapeutics to market faster, advancing the journey to precision medicine.
AI-powered tools can serve as an extra set of “eyes,” helping clinicians to quickly detect and measure anomalies, uplevel surgeons' skills, enhance image quality, and optimize workflows.
AI-powered tools can be an extra set of “eyes,” helping clinicians to quickly read images, calculate measurements, monitor changes, and identify urgent findings to optimize workflows and enhance patient care.
Our solutions for the healthcare industry go beyond products. Our partners are here to assist your organization at every level to build and execute transformative AI strategies, products and services.
Stay up to date with the latest healthcare news from NVIDIA.
NVIDIA Privacy Policy